uniQure (QURE) director trades shares, receives RSUs and stock options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
uniQure N.V. director Robert Gut reported a mix of equity grants, option exercises, and share sales in Ordinary Shares. On June 10, 2026, he received 7,550 restricted share units at no cost and a stock option for 13,980 shares with a $26.82 exercise price expiring on June 10, 2036. He also exercised options for 2,645 shares at a $16.04 exercise price.
Across June 10–11, 2026, Gut sold 10,278 shares in open‑market transactions at weighted average prices around the mid‑$26 range, including 2,645 shares sold solely to cover estimated withholding taxes upon RSU vesting. The remaining sales were executed under a Rule 10b5‑1 trading plan adopted on July 8, 2025. After these transactions, he directly holds 32,259 Ordinary Shares.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 10,278 shares ($270,486)
Net Sell
8 txns
Insider
Gut Robert
Role
null
Sold
10,278 shs ($270K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares | 2,726 | $27.06 | $74K |
| Exercise | Stock Option (Right to Buy) | 2,645 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 13,980 | $0.00 | -- |
| Exercise | Ordinary Shares | 2,645 | $16.04 | $42K |
| Sale | Ordinary Shares | 2,645 | $26.07 | $69K |
| Sale | Ordinary Shares | 3,127 | $26.03 | $81K |
| Sale | Ordinary Shares | 1,780 | $26.05 | $46K |
| Grant/Award | Ordinary Shares | 7,550 | $0.00 | -- |
Holdings After Transaction:
Ordinary Shares — 32,259 shares (Direct, null);
Stock Option (Right to Buy) — 0 shares (Direct, null)
Footnotes (1)
- The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on July 8, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.01 to $26.53. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.01 to $26.18. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.01 to $26.14 . The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.92 to $27.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. The Stock Option vested in full on February 24, 2023. The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.
Key Figures
Shares sold: 10,278 shares
Option exercise size: 2,645 shares
Option exercise price: $16.04 per share
+5 more
8 metrics
Shares sold
10,278 shares
Ordinary Shares sold in open-market transactions on June 10–11, 2026
Option exercise size
2,645 shares
Ordinary Shares acquired via option exercise at $16.04 on June 10, 2026
Option exercise price
$16.04 per share
Exercise price for 2,645-share stock option converted into Ordinary Shares
New RSU grant
7,550 units
Restricted share units granted June 10, 2026 under 2014 Share Incentive Plan
New stock option grant
13,980 shares at $26.82
Stock Option (Right to Buy) expiring June 10, 2036
Holdings after transactions
32,259 shares
Ordinary Shares directly owned after June 11, 2026 trades
Highest disclosed sale price
$27.06 per share
Open-market sale of 2,726 Ordinary Shares on June 11, 2026
10b5-1 plan adoption date
July 8, 2025
Sales plan governing reported transactions intended to comply with Rule 10b5-1
Key Terms
Rule 10b5-1, restricted share units, withholding taxes, Stock Option (Right to Buy), +1 more
5 terms
Rule 10b5-1 regulatory
"intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
withholding taxes financial
"shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes"
Withholding taxes are amounts a payer or government takes out of payments — such as wages, interest, or dividends — before the recipient gets the money, functioning like a cashier keeping part of a bill to pay taxes on your behalf. For investors this matters because it reduces the cash they actually receive, affects net returns and yield calculations, and may require additional paperwork or treaty claims to recover or offset the withheld amount against final tax bills.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with 13,980 underlying Ordinary Shares"
weighted average price financial
"The price reported in Column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
FAQ
What insider transactions did uniQure (QURE) director Robert Gut report?
Robert Gut reported equity grants, an option exercise, and share sales. He received 7,550 restricted share units, new options for 13,980 shares, exercised options for 2,645 shares, and sold 10,278 Ordinary Shares in several open-market transactions.
What equity awards did Robert Gut receive from uniQure (QURE)?
He received 7,550 restricted share units and a stock option covering 13,980 Ordinary Shares. The option has a $26.82 exercise price and expires on June 10, 2036, and both awards vest 100% on the first anniversary of the grant date, subject to continued service.